Iatrogenic nephrotoxicity.
John Cook Renal Unit/Joslin Diabetes Center, Department of Internal Medicine, New England Deaconess Hospital, Boston, MA 02215.
J A
JA
D'Elia
L A
LA
Weinrauch
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008094:Lithium / Q000009:adverse effects; D050607:Organogold Compounds
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D003287:Contrast Media; D050607:Organogold Compounds; D008094:Lithium; D002945:Cisplatin